Agency Information Collection Activities: Proposed Collection; Comment Request, 23768-23769 [2013-09413]
Download as PDF
<![CDATA[
23768
Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices
ACHS–II. Data collection will be
managed by the University of Alabama
at Birmingham (UAB) and the Calhoun
County Health Department (CCHD).
A sample of 500 surviving ACHS
cohort members with PCBs
measurements will be enrolled in the
ACHS–II. After informed consent,
clinical assessments will be done. These
will be for blood pressure, height,
weight, hip, and body girth. A
questionnaire will be answered by
computer-assisted personal interviews
(CAPIs). Questions will be asked for
health, demographic, diet, and lifestyle
factors. The self-reported responses will
be compared to laboratory analytes. For
these, blood samples will be drawn and
analyzed.
The ACHS–II will measure the same
serum PCBs as in the first Anniston
survey. In this way, changes in PCB
levels can be studied. The ACHS–II will
also include serum analytes for dioxins,
furans, dioxin-like PCBs, and
chlorinated pesticides. Additional
analytes include blood measures of
polybrominated biphenyls and heavy
metals. Clinical biomarkers will include
measures for thyroid, diabetes, lipids,
and immune function. This will give a
more complete profile of human
exposures and health in Anniston, AL.
The ATSDR is requesting a two-year
approval for this information collection.
The total annualized burden is 227
hours.
There are no costs to respondents
other than their time. Each respondent
will spend about 2 hours in the study.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Adults who took part in first Anniston Community Health Survey.
Recruitment Telephone Script .......................
Survey for Refusals ........................................
Update Contact Information Form .................
Medications Form ...........................................
Blood Draw Form ...........................................
Questionnaire .................................................
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–09363 Filed 4–19–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Developing Research Capacity
to Assess Health Effects Associated with
Volcanic Emissions and other
Environmental Exposures, Funding
Opportunity Announcement (FOA)
EH13–002, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
Time and Date: 1:00 p.m.–4:00 p.m.,
June 18, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
VerDate Mar<15>2010
17:03 Apr 19, 2013
Jkt 229001
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Developing Research Capacity to
Assess Health Effects Associated with
Volcanic Emissions and other
Environmental Exposures, FOA EH–13–
002’’.
Contact Person for More Information:
J. Felix Rogers, Ph.D., M.P.H., Scientific
Review Officer, CDC, 4770 Buford
Highway, NE., Mailstop F63, Atlanta,
Georgia 30341, Telephone: (770) 488–
4334.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign FEDERAL REGISTER
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–09403 Filed 4–19–13; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
333
160
250
250
250
250
Number of
responses per
respondent
Average
burden per
response
(in hrs)
1
1
1
1
1
1
2/60
1/60
1/60
3/60
2/60
45/60
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10151]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Reinstatement with change of a
previously approved collection; Title of
Information Collection: Data Collection
AGENCY:
E:\FR\FM\22APN1.SGM
22APN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 77 / Monday, April 22, 2013 / Notices
for Medicare Beneficiaries Receiving
Implantable Cardioverter-Defibrillators
for Primary Prevention of Sudden
Cardiac Death; Use: CMS provides
coverage for implantable cardioverterdefibrillators (ICDs) for secondary
prevention of sudden cardiac death
based on extensive evidence showing
that use of ICDs among patients with a
certain set of physiologic conditions are
effective. Accordingly, CMS considers
coverage for ICDs reasonable and
necessary under Section 1862(a)(1)(A) of
the Social Security Act. However,
evidence for use of ICDs for primary
prevention of sudden cardiac death is
less compelling for certain patients.
To encourage responsible and
appropriate use of ICDs, CMS issued a
‘‘Decision Memo for Implantable
Defibrillators’’ on January 27, 2005,
indicating that ICDs will be covered for
primary prevention of sudden cardiac
death if the beneficiary is enrolled in
either an FDA-approved category B IDE
clinical trial (42 CFR 405.201), a trial
under the CMS Clinical Trial Policy
(NCD Manual § 310.1) or a qualifying
prospective data collection system
(either a practical clinical trial or
prospective systematic data collection,
which is sometimes referred to as a
registry). Form Number: CMS–10151
(OMB#: 0938–0967); Frequency:
Occasionally; Affected Public: Private
Sector; Business or other for-profits,
Not-for-profit institutions; Number of
Respondents: 1,702; Total Annual
Responses: 82; Total Annual Hours:
139,356. (For policy questions regarding
this collection contact JoAnna Baldwin
at 410–786–7205. For all other issues
call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by June 21, 2013:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
VerDate Mar<15>2010
17:03 Apr 19, 2013
Jkt 229001
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: April 17, 2013.
Martique Jones,
Deputy Director, Regulations Development
Group, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2013–09413 Filed 4–19–13; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Numbers: 93.581, 93.587, 93.612]
Notice of Final Issuance on the
Adoption of Administration for Native
Americans (ANA) Program Policies
and Procedures
Administration for Native
Americans (ANA), ACF, HHS.
ACTION: Issuance of Final Policy
Directive.
AGENCY:
The Administration for
Native Americans (ANA) is issuing final
interpretive rules, general statements of
policy and rules of agency organization,
procedure, or practice relating to the
following Funding Opportunity
Announcements (FOAs): Social and
Economic Development Strategies
(hereinafter referred to as SEDS),
SEDS—Native Asset Building Initiative
(hereinafter referred to as NABI),
Sustainable Employment and Economic
Development Strategies (hereinafter
referred to as SEEDS), Native Language
Preservation and Maintenance
(hereinafter referred to as Language
Preservation), Native Language
Preservation and Maintenance—Esther
Martinez Initiative (hereinafter referred
to as Language—EMI), and
Environmental Regulatory Enhancement
(hereinafter referred to as ERE). This
notice also provides information about
how ANA will administer these
programs.
SUMMARY:
The policies noted in the original
Notice of Public Comment (NOPC) are
effective immediately upon publication.
FOR FURTHER INFORMATION CONTACT:
Carmelia Strickland, Director, Division
of Program Operations, ANA (877) 922–
9262.
DATES:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
23769
Section
814 of the Native Americans Programs
Act of 1974, as amended, requires ANA
to provide notice of its proposed
interpretive rules, general statements of
policy, and rules of agency organization,
procedure or practice. The proposed
clarifications, modifications, and new
text will appear in the six FY 2013
FOAs: SEDS, NABI, SEEDS, Language
Preservation, Language—EMI, and ERE.
ANA published a NOPC in the Federal
Register (78 FR 13062) on February 26,
2013, with proposed policy and
program clarifications, modifications,
and activities for the fiscal year (FY)
2013 FOAs. The public comment period
was open for 30 days.
For information on the changes ANA
is making, please refer to the NOPC at
the following link: https://www.federal
register.gov/articles/2013/02/26/201304383/request-for-public-comment-onthe-proposed-adoption-ofadministration-for-native-americansprogram.
ANA received one comment from a
Native non-profit organization. ANA
considered the comment received and
provides responses, clarifications, and
modifications in this final directive. The
following paragraph summarizes the
comment and our response:
SUPPLEMENTARY INFORMATION:
A. Comment and Response
Comment: ANA received one
comment in reference to ANA’s new
administrative policy focused on
conflict of interest standards that states
that staff employed through an ANAfunded project cannot also serve as a
member of the governing body for the
applicant organization. Therefore, staff
employed through an ANA-funded
project cannot also serve as a member of
the governing body for the applicant
organization. During the award
negotiation phase, ANA will ask the
prospective recipient to modify project
personnel if a proposed staff member is
also a member of the applicant
organization’s governing body. In
addition, there should be a separation of
duties from staff and the governing
bodies within an organization to ensure
the integrity of internal controls and to
minimize disruptions in the continuity
of operations.
The commenter stated that this policy
would have a negative impact on the
commenter’s organization’s ability to
implement a grant as it currently allows
two teachers to serve as members of the
school board, as required by their
bylaws. If this policy were
implemented, the applicant would not
have the ability to modify project
personnel to align with this policy due
to the extreme shortage of certified
E:\FR\FM\22APN1.SGM
22APN1
]]>Agencies
[Federal Register Volume 78, Number 77 (Monday, April 22, 2013)]
[Notices]
[Pages 23768-23769]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09413]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers CMS-10151]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: Reinstatement with
change of a previously approved collection; Title of Information
Collection: Data Collection
[[Page 23769]]
for Medicare Beneficiaries Receiving Implantable Cardioverter-
Defibrillators for Primary Prevention of Sudden Cardiac Death; Use: CMS
provides coverage for implantable cardioverter-defibrillators (ICDs)
for secondary prevention of sudden cardiac death based on extensive
evidence showing that use of ICDs among patients with a certain set of
physiologic conditions are effective. Accordingly, CMS considers
coverage for ICDs reasonable and necessary under Section 1862(a)(1)(A)
of the Social Security Act. However, evidence for use of ICDs for
primary prevention of sudden cardiac death is less compelling for
certain patients.
To encourage responsible and appropriate use of ICDs, CMS issued a
``Decision Memo for Implantable Defibrillators'' on January 27, 2005,
indicating that ICDs will be covered for primary prevention of sudden
cardiac death if the beneficiary is enrolled in either an FDA-approved
category B IDE clinical trial (42 CFR 405.201), a trial under the CMS
Clinical Trial Policy (NCD Manual Sec. 310.1) or a qualifying
prospective data collection system (either a practical clinical trial
or prospective systematic data collection, which is sometimes referred
to as a registry). Form Number: CMS-10151 (OMB: 0938-0967);
Frequency: Occasionally; Affected Public: Private Sector; Business or
other for-profits, Not-for-profit institutions; Number of Respondents:
1,702; Total Annual Responses: 82; Total Annual Hours: 139,356. (For
policy questions regarding this collection contact JoAnna Baldwin at
410-786-7205. For all other issues call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995,
or Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
In commenting on the proposed information collections please
reference the document identifier or OMB control number. To be assured
consideration, comments and recommendations must be submitted in one of
the following ways by June 21, 2013:
1. Electronically. You may submit your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number ------, Room C4-26-05, 7500 Security Boulevard,
Baltimore, Maryland 21244-1850.
Dated: April 17, 2013.
Martique Jones,
Deputy Director, Regulations Development Group, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2013-09413 Filed 4-19-13; 8:45 am]
BILLING CODE 4120-01-P
